CGC IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Canopy Growth Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CGC

BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bakkt Holdings

Tech Corner: AMZN

HELIOGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heliogen, Inc. - HLGN

BBAI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BigBear.ai Holdings, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action - BBAI

United Airlines CEO Scott Kirby slams the budget airline model: 'It's dead'

SIGNING DAY SPORTS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Signing Day Sports, Inc. - SGN

Tesla Rivals To Report May Sales As BYD Launches China EV Price War

How to Find Healthy Stocks in a Fast Food Market

ROSEN, LEADING INVESTOR COUNSEL, Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation - SLQT

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN

ROSEN, LEADING INVESTOR COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ZBIO

DNUT INVESTOR NOTICE: Krispy Kreme, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

ROSEN, LEADING INVESTOR COUNSEL, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NET Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NPWR, NPWR.WS

BKKT Deadline: BKKT Investors with Losses in Excess of $100K Have Opportunity to Lead Bakkt Holdings, Inc. Securities Fraud Lawsuit

Google says it will appeal online search antitrust decision

Chatham Lodging Trust: Grabbing An 8.2% Return On Preferred Equity

SDS: A Good Hedging Tool With A Caveat

American Eagle Outfitters Deserves To Fly Higher

OGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Salesforce: You May Not Get It This Cheap Again (Rating Upgrade)

Claros Mortgage Trust: A High Risk, High Reward Bet On Commercial Property Turnaround

‘It Is Going to Happen': JPMorgan CEO Jamie Dimon Warns of Crack in the Bond Market

2 High-Quality Dividend Stocks Under $50 for Retirees

ECAT: Saba's Activism Drives Double-Digit Yield, Upcoming Vote Is Key

How Tesla lost some of its biggest fans

TASK Investigation: Kessler Topaz Meltzer & Check, LLP Encourages TaskUs, Inc. (NASDAQ:TASK) Investors to Contact the Firm

INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Broadmark Realty Capital Inc., Ready Capital Corporation, Others and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit – BRMK; RC

BUG: Cybersecurity Needs Growing As AI Proliferates (Rating Upgrade)

Blockmate chairman discusses Bitcoin mining strategy - ICYMI

CVR Energy: Recovery Can Continue

Better AI Stock: Palantir vs. BigBear.ai

Income Or Safety? I Demand Both

2 Extraordinary Ultra-High Yield Stocks to Buy Hand Over Fist

Prediction: Caterpillar's Stock Becomes a Buy When This Key Number Turns Around

Pfizer (PFE) CEO on Braftovi Reducing Colorectal Cancer Death Risk "in Half"

June 2025 Watchlist: Best Canadian Cannabis Stocks for Growth

This Terrific Dividend Stock Is Spending $5.6 Billion to Add Even More Fuel to Its Dividend Growth Engine

Best Stock to Buy Right Now: Apple vs. Chipotle

Vale: Betting On Buybacks And Relevant Upside

Ford recalls more than 29,000 vehicles in the US, NHTSA says

RISR: 17% CAGR. Great For Hedging, But Rate Risk Looms

3 Reasons to Buy This Top Auto Stock Before It's Too Late

URGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Palantir, JPMorgan Chase Lead Five Stocks Near Buy Points

Excellon Resources accelerates restart of Mallay mine with new funding

atai Life Sciences expects key trial data by mid-2025 - ICYMI

IVV: S&P 500 Dashboard For June

Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look

This stock to pay Warren Buffett $200 million in dividends on July 1; Should you buy?

How Will SAIC Stock React To Its Upcoming Earnings?

Will CRDO Stock Rise After Earnings?

Armada Hoffler: The Knife Has Fallen, Time To Pick It Up

Sanofi: Finding Value In The Wake Of Itepekimab's Disappointment

Where Will Archer Aviation Be in 3 Years?

What's Happening With HIMS Stock?

Billionaire Stanley Druckenmiller Just Bet Big On These 2 Stocks

Dell: AI Growth Still Severely Under-Rated

The Fed Just Won't Cut - 5 Stocks To See It Through

Kuaishou Technology: High-Teens EPS Growth Is Plausible

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avis Budget Group

I'm Buying CrowdStrike Before Earnings As The Market Is Underestimating The Growth Story (Upgrade)

Phreesia: Monetization Playbook To Help Drive Revenue Acceleration

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BigBear.ai

Canadian Natural Resources: My Number 1 Energy Pick

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of NET Power

Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model

Potentially Earn 12%-15% Income: Monthly Options Series (June 2025)

Match Group: A Love Connection With Value Investors

3 Overlooked Dividend Plays for Income in Volatile Times

U.S. Holds $773B in Gold and FX Reserves—More Than Germany, Italy, and France Combined

Analyst sets date when Nvidia stock will hit $200

Lyft is starting to make some right moves with urging from activist Engine Capital. What's next

Shoe Carnival's Transformation Offers Upside

3 Reasons This Artificial Intelligence Stock Could Have the Biggest Comeback in 2025

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Open Lending

ispace Completes Success 8 of Mission 2 Milestones

Aftermath Silver CEO discuss near-surface drill success - ICYMI

Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression

New data show Roche's Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Napco Security Technologies

In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment Decisions

AutoZone: Double-Digit Growth Amidst A Slowing Economy Makes It A Long-Term Buy

monday.Com: Exceptional Buy As New Products And Upmarket Push Take Off (Upgrade)

Tesla can't just hit ‘undo' on Elon's D.C. adventure

Nomura Forecast: Overvalued Dollar Set to Weaken Further, End-2026 USD/JPY Forecast 130

So Cheap It's Silly - 2 Dividend Stocks I'd Buy Twice If I Could

What's Driving the Success of Palantir Stock?

47% of Berkshire Hathaway's $276 Billion Warren Buffett-Led Portfolio Is Invested in 3 Dividend Stocks

MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy

AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition

The Smartest High-Yield Stocks to Buy With $100 Right Now

OGN CLASS NOTICE: Organon & Co. Investors may have been Affected by Fraud – Contact BFA Law before July 22 Court Deadline (NYSE:OGN)

IOVA CLASS NOTICE: Iovance Biotherapeutics, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 14 Court Deadline (NASDAQ:IOVA)